Extrapyramidal and cognitive signs in amyotrophic lateral sclerosis: A population based cross-sectional study

References

• Chiò A, Calvo A, Moglia C, Mazzini L, Mora G; PARALS study group. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82:740–6.
   PubMed Web of Science ®Google Scholar
• Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, et al. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14 (Suppl 1):5–18.
   PubMed Web of Science ®Google Scholar
• Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6: 994–1003.
   PubMed Web of Science ®Google Scholar
• Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet. 1993;342:1016–8.
   PubMed Web of Science ®Google Scholar
• Desai J, Swash M. Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion. J Neurol Neurosurg Psychiatry. 1999;67:214–6.
   PubMed Web of Science ®Google Scholar
• D’Ascenzo C, Cecchin D, Santelli L, Palmieri A, Gaiani A, Querin G, et al. Parkinson-like features in ALS with predominant upper motor neuron involvement. Amyotroph Lateral Scler. 2012;13:137–43.
   PubMed Web of Science ®Google Scholar
• Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol. 2008;65:636–41.
   PubMed Web of Science ®Google Scholar
• McCluskey LF, Elman LB, Martinez-Lage M, van Deerlin V, Yuan W, Clay D, et al. Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology. Arch Neurol. 2009;66:121–4.
   PubMed Web of Science ®Google Scholar
• Brettschneider J, Arai K, del Tredici K, Toledo JB, Robinson JL, Lee EB, et al. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014;128:423–37.
   PubMed Web of Science ®Google Scholar
• Steele JC, McGeer PL. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology. 2008;70:1984–90.
   PubMed Web of Science ®Google Scholar
• Wolf Gilbert RM, Fahn S, Mitsumoto H, Rowland LP. Parkinsonism and motor neuron diseases: 27 patients with diverse overlap syndromes. Mov Disord. 2010;25:1868–75.
   PubMed Web of Science ®Google Scholar
• Manno C, Lipari A, Bono V, Taiello AC, La Bella V. Sporadic Parkinson's disease and amyotrophic lateral sclerosis complex (Brain-Fahn-Schwartz disease). J Neuol Sci. 2013;326: 104–6.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Quaranta D, Conte A, Lattante S, Romano A, Silvestri G, et al. Frontotemporal dementia, Parkinsonism and lower motor neuron involvement in a patient with C9orf72 expansion. Amyotroph Lateral Scler. 2013;14: 66–9.
   Web of Science ®Google Scholar
• Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.
   PubMed Web of Science ®Google Scholar
• McCluskey L, Vandriel S, Elman L, van Deerlin VM, Powers J, Boller A, et al. ALS-plus syndrome: non-pyramidal features in a large ALS cohort. J Neurol Sci. 2014;345: 118–24.
   PubMed Web of Science ®Google Scholar
• Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85:867–72.
   PubMed Web of Science ®Google Scholar
• Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G; SLALOM Group. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141–5.
   PubMed Web of Science ®Google Scholar
• Georgoulopoulou E, Vinceti M, Bonvicini F, Sola P, Goldoni CA, de Girolamo G, et al. Changing incidence and subtypes of ALS in Modena, Italy: a 10-years prospective study. Amyotroph Lateral Scler. 2011;12:451–7.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci. 1994;124 (Suppl): 96–107.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. Mini Mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
   PubMed Web of Science ®Google Scholar
• Dubois B, Slachevsky A, Litvan I, Pillon B. A frontal assessment battery at bedside. The FAB. Neurology. 2000;55:1621–6.
   PubMed Web of Science ®Google Scholar
• Slachevsky A, Villalpando JM, Sarazin M, Hahn-Barma V, Pillon B, Dubois B. Frontal assessment battery and differential diagnosis of frontotemporal dementia and Alzheimer’S disease. Arch Neurol. 2004;61:1104–7.
   PubMed Web of Science ®Google Scholar
• Appollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, et al. The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci. 2005;26:108–16.
   PubMed Web of Science ®Google Scholar
• Magni E, Binetti G, Bianchetti A, Rozzini R, Trabucchi M. Mini-Mental State Examination: a normative study in Italian elderly population. Eur J Neurol. 1996;3:198–202.
   PubMed Web of Science ®Google Scholar
• Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population based study in Italy. J Neurol Neurosurg Psychiatry 2014 doi: 10.1136/jnnp-2013-307223. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65: 586–90.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 2012; 124:339–52.
   PubMed Web of Science ®Google Scholar
• Funkenstein HH, Albert MS, Cook NR, West CG, Scherr PA, Chown MJ, et al. Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer’s disease. A community based study. Arch Neurol. 1993;50:51–6.
   PubMed Web of Science ®Google Scholar
• Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: Evidence of shared genetic susceptibility. Neurology. 1994;44:1872–7.
   PubMed Web of Science ®Google Scholar
• Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, et al. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Ann Neurol. 2013;74: 699–708.
   PubMed Web of Science ®Google Scholar
• Kieburtz K, Wunderle KB. Parkinson’s disease: evidence for environmental risk factors. Mov Disord. 2013;28:8–13.
   PubMed Web of Science ®Google Scholar
• Sutherland GT, Siebert GA, Kril JJ, Mellick GD. Knowing me, knowing you: can a knowledge of risk factors for Alzheimer’s disease prove useful in understanding the pathogenesis of Parkinson’s disease? J Alzheimers Dis. 2011;25:395–415.
   PubMed Web of Science ®Google Scholar
• van Es MA, Schelhaas HJ, van Vught PWJ, LeClerc AL, Keagle P, Bloem BR, et al. Angiogenin variants in Parkinson's disease and amyotrophic lateral sclerosis. Ann Neurol. 2011;70:964–73.
   PubMed Web of Science ®Google Scholar
• Fujita Y, Ikeda M, Yanagisawa T, Senoo Y, Okamoto K. Different clinical and neuropathologic phenotypes of familial ALS with A315E TARDPB mutation. Neurology. 2011;77:1427–31.
   PubMed Web of Science ®Google Scholar
• Mandrioli J, Biguzzi S, Guidi C, Venturini E, Sette E, Terlizzi E, et al. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:262–8.
   PubMed Web of Science ®Google Scholar
• Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology. 2001;56:239–44.
   PubMed Web of Science ®Google Scholar
• Oskarsson B, Quan D, Rollins YD, Neville HE, Ringel SP, Arciniegas DB. Using the Frontal Assessment Battery to identify executive function impairment in amyotrophic lateral sclerosis: a preliminary experience. Amyotroph Lateral Scler. 2010;11:244–7.
   PubMed Web of Science ®Google Scholar